Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,685 | 688 | 99.4% |
| Education | $61.38 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,650 | 141 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,391 | 67 | $0 (2024) |
| Novo Nordisk Inc | $989.18 | 84 | $0 (2024) |
| Lilly USA, LLC | $940.62 | 64 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $597.77 | 53 | $0 (2024) |
| ABBVIE INC. | $582.60 | 45 | $0 (2024) |
| PFIZER INC. | $457.58 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $391.65 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $301.02 | 24 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $259.74 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,551 | 102 | Amgen Inc. ($326.95) |
| 2023 | $1,603 | 114 | AstraZeneca Pharmaceuticals LP ($244.19) |
| 2022 | $1,015 | 70 | Novo Nordisk Inc ($184.04) |
| 2021 | $1,813 | 125 | Lilly USA, LLC ($262.03) |
| 2020 | $917.68 | 68 | Amgen Inc. ($192.11) |
| 2019 | $685.89 | 53 | Amgen Inc. ($237.90) |
| 2018 | $983.06 | 67 | AstraZeneca Pharmaceuticals LP ($262.27) |
| 2017 | $1,177 | 94 | Amgen Inc. ($210.71) |
All Payment Transactions
693 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Bone Health | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Gastroenterology | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Gastroenterology | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Gastroenterology | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,010 | 1,978 | $277,403 | $89,161 |
| 2022 | 10 | 970 | 1,837 | $273,741 | $83,985 |
| 2021 | 7 | 861 | 1,826 | $242,033 | $90,423 |
| 2020 | 9 | 920 | 1,983 | $232,757 | $82,143 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 295 | 810 | $202,448 | $60,611 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 177 | $30,267 | $9,250 | 30.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 50 | 50 | $9,900 | $5,923 | 59.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 306 | 687 | $19,923 | $5,740 | 28.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 92 | 95 | $4,180 | $2,668 | 63.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 93 | 96 | $3,168 | $2,078 | 65.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,290 | $1,591 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $2,783 | $1,219 | 43.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 37 | $444.00 | $81.40 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 302 | 794 | $198,500 | $59,997 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 186 | $31,806 | $9,292 | 29.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $8,316 | $5,138 | 61.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 22 | $5,566 | $2,860 | 51.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 293 | 607 | $17,603 | $1,790 | 10.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $5,720 | $1,743 | 30.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 62 | 62 | $2,728 | $1,651 | 60.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 64 | 64 | $2,112 | $1,350 | 63.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 14 | $1,078 | $106.23 | 9.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 26 | $312.00 | $57.55 | 18.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 306 | 847 | $171,065 | $66,346 | 38.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 151 | 244 | $34,574 | $13,433 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 30 | 30 | $5,940 | $3,773 | 63.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 25 | $6,325 | $3,063 | 48.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $5,720 | $1,867 | 32.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 303 | 617 | $17,893 | $1,843 | 10.3% |
About Dr. Sean Pfeffer, MD
Dr. Sean Pfeffer, MD is a Family Medicine healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487690913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Pfeffer, MD has received a total of $9,746 in payments from pharmaceutical and medical device companies, with $1,551 received in 2024. These payments were reported across 693 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($9,685).
As a Medicare-enrolled provider, Pfeffer has provided services to 3,761 Medicare beneficiaries, totaling 7,624 services with total Medicare billing of $345,712. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Joplin, MO
- Active Since 06/22/2006
- Last Updated 09/30/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487690913
Products in Payments
- XIFAXAN (Drug) $597.77
- BREZTRI (Drug) $521.88
- FARXIGA (Drug) $520.47
- EVENITY (Biological) $436.00
- Ozempic (Drug) $415.10
- TRULICITY (Drug) $407.29
- Otezla (Drug) $397.92
- Prolia (Biological) $344.48
- Aimovig (Biological) $309.93
- XARELTO (Drug) $260.83
- TRELEGY ELLIPTA (Drug) $256.62
- Rybelsus (Drug) $227.80
- JARDIANCE (Drug) $211.08
- QULIPTA (Drug) $209.10
- SYMBICORT (Drug) $181.60
- UBRELVY (Drug) $168.92
- Repatha (Biological) $161.60
- BEVESPI AEROSPHERE (Drug) $148.60
- Kerendia (Drug) $145.14
- LYRICA (Drug) $139.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Joplin
Dr. Luke Wicke, Do, DO
Family Medicine — Payments: $14,984
Dr. Maria Fe Bruce, Md, MD
Family Medicine — Payments: $12,947
Troy D'amour, Do, DO
Family Medicine — Payments: $11,869
James Dailey, D.o, D.O
Family Medicine — Payments: $9,990
William Hughes, Do, DO
Family Medicine — Payments: $7,047
Amanda Andrade, Do, DO
Family Medicine — Payments: $6,472